Publicaciones en colaboración con investigadores/as de University Hospital of Lausanne (19)

2024

  1. Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment

    Methods in Cell Biology (Academic Press Inc.), pp. 79-97

  2. Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

    Clinical Cancer Research, Vol. 30, Núm. 8, pp. 1630-1641

2023

  1. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

    Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53

  2. Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

    Frontiers in Immunology, Vol. 14

  3. Revisiting the outcome of adult wild-Type Htt inactivation in the context of HTT-lowering strategies for Huntington's disease

    Brain Communications, Vol. 5, Núm. 6

2022

  1. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients

    Haematologica, Vol. 107, Núm. 3, pp. 593-603

  2. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  3. Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis

    Hepatology, Vol. 75, Núm. 4, pp. 968-982

  4. TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

    Cancers, Vol. 14, Núm. 15

2021

  1. CD40 agonist targeted to fibroblast activation protein a synergizes with radiotherapy in murine HPV-positive head and neck tumors

    Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4054-4065

  2. Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity

    Journal of Experimental Medicine, Vol. 218, Núm. 6

2020

  1. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1

  2. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells

    Frontiers in Immunology, Vol. 11

  3. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer

    European Journal of Cancer, Vol. 135, pp. 173-182

2019

  1. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 7, Núm. 1

2017

  1. Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function

    PLoS ONE, Vol. 12, Núm. 7

  2. Editorial: Cancer immunotherapy full speed ahead

    Annals of Oncology

2015

  1. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

    Leukemia, Vol. 29, Núm. 5, pp. 1177-1185

2014

  1. T-cell and NK-cell infiltration into solid tumors: A key limiting factor for efficacious cancer immunotherapy

    Cancer Discovery, Vol. 4, Núm. 5, pp. 522-526